Literature DB >> 28043982

Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression.

M Takeshita1, S Anai1, S Mishima1, K Inoue1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28043982     DOI： 10.1093/annonc/mdw537

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

Review 1.  Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.

Authors:  Masood Sadaat; Sekwon Jang
Journal:  J Immunother Cancer       Date:  2018-06-05       Impact factor: 13.751

2.  Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.

Authors:  Osamu Honjo; Terufumi Kubo; Fumiko Sugaya; Takahiro Nishizaka; Koji Kato; Yoshihiko Hirohashi; Hiroki Takahashi; Toshihiko Torigoe
Journal:  J Immunother Cancer       Date:  2019-04-03       Impact factor: 13.751

3.  Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.

Authors:  Roberta Noseda; Raffaela Bertoli; Laura Müller; Alessandro Ceschi
Journal:  J Immunother Cancer       Date:  2019-05-02       Impact factor: 13.751

4.  Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.

Authors:  James Kalmuk; Jon Puchalla; Gong Feng; Anshu Giri; John Kaczmar
Journal:  Cancers Head Neck       Date:  2020-02-03

Review 5.  Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.

Authors:  Jaime Rubio-Perez; Ángel Ricardo Rodríguez-Perez; María Díaz-Blázquez; Victor Moreno-García; Manuel Dómine-Gómez
Journal:  J Med Case Rep       Date:  2022-10-04

6.  A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy.

Authors:  Hidenori Takahashi; Tomohiro Koiwa; Akira Fujita; Takayuki Suzuki; Amane Tagashira; Yoshinobu Iwasaki
Journal:  Respir Med Case Rep       Date:  2020-05-19

7.  Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Nabil E Omar; Kareem A El-Fass; Abdelrahman I Abushouk; Noha Elbaghdady; Abd Elmonem M Barakat; Ahmed E Noreldin; Dina Johar; Mohamed Yassin; Anas Hamad; Shereen Elazzazy; Said Dermime
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.